| Clofazimine: current status and future prospects MC Cholo, HC Steel, PB Fourie, WA Germishuizen, R Anderson Journal of antimicrobial chemotherapy 67 (2), 290-298, 2012 | 387 | 2012 |
| HIV as a cause of immune activation and immunosenescence T Sokoya, HC Steel, M Nieuwoudt, TM Rossouw Mediators of inflammation 2017 (1), 6825493, 2017 | 182 | 2017 |
| Pathogen‐and host‐directed anti‐inflammatory activities of macrolide antibiotics HC Steel, AJ Theron, R Cockeran, R Anderson, C Feldman Mediators of inflammation 2012 (1), 584262, 2012 | 158 | 2012 |
| The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance T Kostyanev, MJM Bonten, S O'brien, H Steel, S Ross, B François, ... Journal of antimicrobial chemotherapy 71 (2), 290-295, 2016 | 151 | 2016 |
| Overview of community‐acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease HC Steel, R Cockeran, R Anderson, C Feldman Mediators of inflammation 2013 (1), 490346, 2013 | 151 | 2013 |
| Proinflammatory interactions of pneumolysin with human neutrophils R Cockeran, AJ Theron, HC Steel, NM Matlola, TJ Mitchell, C Feldman, ... The Journal of infectious diseases 183 (4), 604-611, 2001 | 150 | 2001 |
| Cysteinyl leukotriene receptor‐1 antagonists as modulators of innate immune cell function AJ Theron, HC Steel, GR Tintinger, CM Gravett, R Anderson, C Feldman Journal of immunology research 2014 (1), 608930, 2014 | 140 | 2014 |
| Montelukast inhibits neutrophil pro‐inflammatory activity by a cyclic AMP‐dependent mechanism R Anderson, AJ Theron, CM Gravett, HC Steel, GR Tintinger, C Feldman British journal of pharmacology 156 (1), 105-115, 2009 | 108 | 2009 |
| Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control G Tintinger, HC Steel, R Anderson Clinical & Experimental Immunology 141 (2), 191-200, 2005 | 84 | 2005 |
| Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin ND Mutepe, R Cockeran, HC Steel, AJ Theron, TJ Mitchell, C Feldman, ... European Respiratory Journal 41 (2), 392-395, 2013 | 79 | 2013 |
| Changes in serum cytokines after repeated bouts of downhill running LL Smith, AJ McKune, SJ Semple, E Sibanda, H Steel, R Anderson Applied physiology, nutrition, and metabolism 32 (2), 233-240, 2007 | 79 | 2007 |
| Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in … R Anderson, HC Steel, R Cockeran, A Von Gottberg, L De Gouveia, ... Journal of Antimicrobial Chemotherapy 60 (5), 1155-1158, 2007 | 78 | 2007 |
| The role of transforming growth factor beta-1 in the progression of HIV/AIDS and development of non-AIDS-defining fibrotic disorders AJ Theron, R Anderson, TM Rossouw, HC Steel Frontiers in immunology 8, 1461, 2017 | 76 | 2017 |
| Pneumolysin Potentiates Production of Prostaglandin E2 and Leukotriene B4 by Human Neutrophils R Cockeran, HC Steel, TJ Mitchell, C Feldman, R Anderson Infection and immunity 69 (5), 3494-3496, 2001 | 71 | 2001 |
| Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus … R Anderson, HC Steel, R Cockeran, AM Smith, A Von Gottberg, ... Journal of Antimicrobial Chemotherapy 59 (2), 224-229, 2007 | 64 | 2007 |
| Effects of clofazimine on potassium uptake by a Trk-deletion mutant of Mycobacterium tuberculosis MC Cholo, HI Boshoff, HC Steel, R Cockeran, NM Matlola, KJ Downing, ... Journal of Antimicrobial Chemotherapy 57 (1), 79-84, 2006 | 63 | 2006 |
| Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting? AJ Theron, HC Steel, GR Tintinger, C Feldman, R Anderson Drug design, development and therapy, 1387-1398, 2013 | 61 | 2013 |
| High mobility group box 1 in human cancer BL Rapoport, HC Steel, AJ Theron, L Heyman, T Smit, Y Ramdas, ... Cells 9 (7), 1664, 2020 | 56 | 2020 |
| Circulating Biomarkers of Immune Activation Distinguish Viral Suppression from Nonsuppression in HAART‐Treated Patients with Advanced HIV‐1 Subtype C Infection G Malherbe, HC Steel, S Cassol, T De Oliveira, CJ Seebregts, ... Mediators of inflammation 2014 (1), 198413, 2014 | 55 | 2014 |
| Inhibition of potassium transport and growth of mycobacteria exposed to clofazimine and B669 is associated with a calcium-independent increase in microbial phospholipase A2 … HC Steel, NM Matlola, R Anderson Journal of Antimicrobial Chemotherapy 44 (2), 209-216, 1999 | 55 | 1999 |
